FCPM III SERVICES B.V. Long-Term Concentrated

CIK: 0002013410 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 3, 2024

Total Value ($000): $707,348 (100.0% shares, 0.0% debt)

Holdings (6)

NAMS NEWAMSTERDAM PHARMA COMPANY 39.6%

Value ($000) $279,814 Shares 11,831,461 Est. Cost $9.16 Unrealized +121.6%

DYN DYNE THERAPEUTICS INC 31.5%

Value ($000) $222,730 Shares 7,845,364 Est. Cost $12.58 Unrealized +79.8%

ENGN ENGENE HOLDINGS INC 20.8%

Value ($000) $147,091 Shares 8,677,951 Est. Cost $10.40 Unrealized +17.7%

REPL REPLIMUNE GROUP INC 5.6%

Value ($000) $39,759 Shares 4,866,449 Est. Cost $11.59 Unrealized -29.3%

ENGNW ENGENE HOLDINGS INC 2.1%

Value ($000) $14,966 Shares 2,878,148 Est. Cost $0.63 Unrealized —

— ACHILLES THERAPEUTICS PLC 0.4%

Value ($000) $2,988 Shares 2,390,050 Est. Cost $0.89 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
NAMS	NEWAMSTERDAM PHARMA COMPANY	11,831,461	$279,814	39.6%	$9.16	+121.6%	ORDINARY SHARES	N62509109
DYN	DYNE THERAPEUTICS INC	7,845,364	$222,730	31.5%	$12.58	+79.8%	COM	26818M108
ENGN	ENGENE HOLDINGS INC	8,677,951	$147,091	20.8%	$10.40	+17.7%	COM	29286M105
REPL	REPLIMUNE GROUP INC	4,866,449	$39,759	5.6%	$11.59	-29.3%	COM	76029N106
ENGNW	ENGENE HOLDINGS INC	2,878,148	$14,966	2.1%	$0.63	—	W EXP 10/31/2028	29286M113
—	ACHILLES THERAPEUTICS PLC	2,390,050	$2,988	0.4%	$0.89	—	SPONSORED ADS	00449L102